Mga Batayang Estadistika
| LEI | 549300N2D5UJZLKQ1O22 |
| CIK | 1453814 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Medidata Solutions, Inc.
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| November 8, 2019 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 14)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Number) Eddie C. Brown Brown Capi |
|
| November 7, 2019 |
MDSO / Medidata Solutions, Inc. 15-12B - - FORM 15-12B 15-12B 1 rip-mdso2009x2019.htm FORM 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-34387 Medidata Solutions, In |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
MDSO / Medidata Solutions, Inc. S-8 POS - - S-8 POS S-8 POS 1 forms8pos.htm S-8 POS As filed with the Securities and Exchange Commission on October 28, 2019 Registration Statement File No. 333-225820 Registration Statement File No. 333-225816 Registration Statement File No. 333-218349 Registration Statement File No. 333-211946 Registration Statement File No. 333-198262 Registration Statement File No. 333-192861 Registration Statement File No. 333-1 |
|
| October 28, 2019 |
AMENDED AND RESTATED CERTIFICATE OF INCORPORATION MEDIDATA SOLUTIONS, INC. Exhibit 3.1 AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MEDIDATA SOLUTIONS, INC. FIRST: The name of the Corporation is Medidata Solutions, Inc. (the “Corporation”). SECOND: The address of the registered office of the Corporation in the State of Delaware is 1209 Orange Street, Wilmington, New Castle County, 19801. The name of its registered agent at that address is The Corporation Trust Co |
|
| October 28, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commissi |
|
| October 28, 2019 |
BY-LAWS MEDIDATA SOLUTIONS, INC. A Delaware Corporation Effective October 28, 2019 TABLE OF CONTENTS Exhibit 3.2 BY-LAWS OF MEDIDATA SOLUTIONS, INC. A Delaware Corporation Effective October 28, 2019 TABLE OF CONTENTS Page Article I OFFICES 1 Section 1.1 Registered Office 1 Section 1.2 Other Offices 1 Article II MEETINGS OF STOCKHOLDERS 1 Section 2.1 Place of Meetings 1 Section 2.2 Annual Meetings 1 Section 2.3 Special Meetings 1 Section 2.4 Notice 2 Section 2.5 Adjournments 2 Section 2.6 Quorum 3 |
|
| September 24, 2019 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 23, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commis |
|
| September 24, 2019 |
Dassault Systèmes announces extension of CFIUS review process for planned acquisition of Medidata Exhibit 99.1 Dassault Systèmes announces extension of CFIUS review process for planned acquisition of Medidata VÉLIZY-VILLACOUBLAY, France and NEW YORK — September 24, 2019 – Dassault Systèmes SE (Dassault Systèmes) (Euronext Paris: #13065, DSY. PA) and Medidata Solutions, Inc. ("Medidata") (NASDAQ: MDSO) announced that the Committee on Foreign Investment in the United States (CFIUS) will initiate |
|
| August 19, 2019 |
Financial Statements and Exhibits, Other Events, Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 16, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Numb |
|
| August 19, 2019 |
Dassault Systèmes Announces Medidata Stockholder Approval for Planned Acquisition EX-99.1 2 nt10004156x1ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Dassault Systèmes Announces Medidata Stockholder Approval for Planned Acquisition VÉLIZY-VILLACOUBLAY, France and NEW YORK — August 19, 2019 – Dassault Systèmes SE (Dassault Systèmes) (Euronext Paris: #13065, DSY. PA) and Medidata Solutions, Inc. (“Medidata”) (NASDAQ: MDSO) announced that Medidata stockholders have approved on August 16, 2 |
|
| August 9, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - DEFA14A DEFA14A 1 formdefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as per |
|
| August 6, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Med |
|
| July 23, 2019 |
Medidata Reports Second Quarter 2019 Results Exhibit 99.1 Medidata Reports Second Quarter 2019 Results NEW YORK-(BUSINESS WIRE)-July 23, 2019-Medidata (NASDAQ:MDSO) today announced its financial results for the second quarter of 2019. “Our good results in the second quarter and for the first half of the year were driven by the strength of our core business,” said Tarek Sherif, chairman and CEO, Medidata. “With our win rate at an all-time hig |
|
| July 23, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 23, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| July 19, 2019 |
definitive proxy statement on Schedule 14A DEFM14A 1 nc10003001x2defm14a.htm DEFM14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of |
|
| July 9, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| July 9, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - DEFA14A DEFA14A 1 salespptslides.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as p |
|
| July 3, 2019 |
MDSO / Medidata Solutions, Inc. PREM14A - - PREM14A PREM14A 1 nc10003001x1prem14a.htm PREM14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: ☒ Preliminary Proxy Statement o Confidential, for Use of |
|
| June 21, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - DEFA14A DEFA14A 1 equityfaqsdefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (a |
|
| June 13, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| June 13, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| June 13, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - SCHEDULE 14A DEFA14A 1 townhall14a.htm SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| June 12, 2019 |
Exhibit 10.1 FORM OF VOTING AGREEMENT THIS VOTING AGREEMENT (hereinafter referred to as this “Agreement”) is made and entered into as of June 11, 2019 by and between Dassault Systèmes Americas Corp., a Delaware corporation (“Parent”), on the one hand, and the undersigned shareholder (the “Shareholder”) of Medidata Solutions, Inc., a Delaware corporation (the “Company”), on the other hand. WHEREAS, |
|
| June 12, 2019 |
EXHIBIT 10.3 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”), dated as of June 11, 2019, by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Medidata Solutions, Inc., a Delaware corporation (the “Company”), and Rouven Bergmann (the “Executive”). WHEREAS, the Company has entered i |
|
| June 12, 2019 |
EXHIBIT 10.2 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”), dated as of June 11, 2019, by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Medidata Solutions, Inc., a Delaware corporation (the “Company”), and Tarek Sherif (the “Executive”). WHEREAS, the Company has entered into |
|
| June 12, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| June 12, 2019 |
EXHIBIT 10.4 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”), dated as of June 11, 2019, by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Medidata Solutions, Inc., a Delaware corporation (the “Company”), and Glen de Vries (the “Executive”). WHEREAS, the Company has entered int |
|
| June 12, 2019 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among DASSAULT SYSTÈMES SE, DASSAULT SYSTÈMES AMERICAS CORP., 3DS ACQUISITION 6 CORP. and MEDIDATA SOLUTIONS, INC. Dated as of June 11, 2019 TABLE OF CONTENTS Page Article I THE MERGER 1.1 The Merger 2 1.2The Effective Time 2 1.3Effect of the Merger 3 1.4Certificate of Incorporation and Bylaws of the Surviving Corporation 3 1.5Directors and Officers |
|
| June 12, 2019 |
Amended and Restated Bylaws of Medidata Solutions, Inc. AMENDED AND RESTATED BYLAWS OF MEDIDATA SOLUTIONS, INC. (as amended on June 11, 2019) TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 NOTICE OF STOCKHOLDERS’ MEETINGS 2 2.5 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE 2 2.6 QUORUM 3 2.7 ADJOU |
|
| June 12, 2019 |
EXHIBIT 10.5 FORM OF LETTER AGREEMENT This Letter Agreement (this “Agreement”), dated as of [●], 2019, is by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Dassault Systèmes Americas Corp., a Delaware corporation and wholly owned subsidiary of Dassault Systèmes (“DSAC”), Medidata Solutions, Inc., a Delaware corpora |
|
| June 12, 2019 |
EXHIBIT 10.4 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”), dated as of June 11, 2019, by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Medidata Solutions, Inc., a Delaware corporation (the “Company”), and Glen de Vries (the “Executive”). WHEREAS, the Company has entered int |
|
| June 12, 2019 |
Exhibit 10.1 FORM OF VOTING AGREEMENT THIS VOTING AGREEMENT (hereinafter referred to as this “Agreement”) is made and entered into as of June 11, 2019 by and between Dassault Systèmes Americas Corp., a Delaware corporation (“Parent”), on the one hand, and the undersigned shareholder (the “Shareholder”) of Medidata Solutions, Inc., a Delaware corporation (the “Company”), on the other hand. WHEREAS, |
|
| June 12, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - FORM 8-K DEFA14A 1 form8-kremergeragreement.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of |
|
| June 12, 2019 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER by and among DASSAULT SYSTÈMES SE, DASSAULT SYSTÈMES AMERICAS CORP., 3DS ACQUISITION 6 CORP. and MEDIDATA SOLUTIONS, INC. Dated as of June 11, 2019 TABLE OF CONTENTS Page Article I THE MERGER 1.1 The Merger 2 1.2The Effective Time 2 1.3Effect of the Merger 3 1.4Certificate of Incorporation and Bylaws of the Surviving Corporation 3 1.5Directors and Officers |
|
| June 12, 2019 |
EXHIBIT 10.5 FORM OF LETTER AGREEMENT This Letter Agreement (this “Agreement”), dated as of [●], 2019, is by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Dassault Systèmes Americas Corp., a Delaware corporation and wholly owned subsidiary of Dassault Systèmes (“DSAC”), Medidata Solutions, Inc., a Delaware corpora |
|
| June 12, 2019 |
EXHIBIT 10.3 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”), dated as of June 11, 2019, by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Medidata Solutions, Inc., a Delaware corporation (the “Company”), and Rouven Bergmann (the “Executive”). WHEREAS, the Company has entered i |
|
| June 12, 2019 |
AMENDED AND RESTATED BYLAWS OF MEDIDATA SOLUTIONS, INC. (as amended on June 11, 2019) TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 NOTICE OF STOCKHOLDERS’ MEETINGS 2 2.5 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE 2 2.6 QUORUM 3 2.7 ADJOU |
|
| June 12, 2019 |
EXHIBIT 10.2 EXECUTIVE EMPLOYMENT AGREEMENT This Executive Employment Agreement (this “Agreement”), dated as of June 11, 2019, by and between Dassault Systèmes SE, a societas Europaea (European company) organized under the laws of France (“Dassault Systèmes”), Medidata Solutions, Inc., a Delaware corporation (the “Company”), and Tarek Sherif (the “Executive”). WHEREAS, the Company has entered into |
|
| June 12, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - SCHEDULE 14A DEFA14A 1 employeefaq14a.htm SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only |
|
| June 12, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - SCHEDULE 14A DEFA14A 1 blogpost6-1214a.htm SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only |
|
| June 12, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - SCHEDULE 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ý Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ¨ Defin |
|
| June 12, 2019 |
Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation For Patient-Centric Experience Through End-to-End Collaborative Platform • Medidata Solutions’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance • Scientific modeling, simulation and digi |
|
| June 12, 2019 |
Financial Statements and Exhibits, Other Events 8-K 1 june11-8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001- |
|
| June 12, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A - - FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| June 12, 2019 |
Press Release issued by Medidata Solutions, Inc., dated June 11, 2019. Dassault Systèmes and Medidata Solutions To Join Forces To Accelerate the Life Sciences Industry Innovation For Patient-Centric Experience Through End-to-End Collaborative Platform • Medidata Solutions’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance • Scientific modeling, simulation and digi |
|
| May 30, 2019 |
Submission of Matters to a Vote of Security Holders 8-K 1 mdso-xform8xkpostagm2019.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 29, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incor |
|
| May 10, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Me |
|
| May 10, 2019 |
Form of Medidata Solutions, Inc. 2019 Performance-Based Restricted Stock Unit Agreement MEDIDATA SOLUTIONS, INC. 2019 PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT is made as of February 12th, 2019, by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and [EXECUTIVE] (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. Amended and Restated 2017 Long-Term Incentive Plan (the “Plan”), the Company hereby grants to the Participant a target |
|
| April 30, 2019 |
Medidata Reports First Quarter 2019 Results Exhibit 99.1 Medidata Reports First Quarter 2019 Results NEW YORK-(BUSINESS WIRE)-April 30, 2019-Medidata (NASDAQ: MDSO) today announced its financial results for the first quarter of 2019. “Medidata is at the forefront of driving the digital transformation of life science with our platform, data assets and industry expertise, helping fulfill the mission we set almost 20 years ago to positively im |
|
| April 30, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51976651.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 30, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction o |
|
| April 18, 2019 |
MDSO / Medidata Solutions, Inc. DEFA14A DEFA14A 1 nc10000949x2defa14.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by R |
|
| April 18, 2019 |
TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 17, 2019 |
Amended and Restated Bylaws of Medidata Solutions, Inc., as amended on April 15, 2019 AMENDED AND RESTATED BYLAWS OF MEDIDATA SOLUTIONS, INC. (as amended on April 15, 2019) TABLE OF CONTENTS ARTICLE I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 1.2 OTHER OFFICES 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 NOTICE OF STOCKHOLDERS’ MEETINGS 2 2.5 MANNER OF GIVING NOTICE; AFFIDAVIT OF NOTICE 2 2.6 QUORUM 3 2.7 ADJOURNED |
|
| April 17, 2019 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 15, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commission |
|
| March 1, 2019 |
Subsidiaries of Medidata Solutions, Inc. EX-21.1 3 subsidiariesoftheregistran.htm SUBSIDIARIES OF MEDIDATA SOLUTIONS, INC. Exhibit 21.1 MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant Subsidiaries* Place of Incorporation MDSOL Europe Limited United Kingdom Medidata Holdings, Inc. Delaware, U.S. Medidata Korea, Limited South Korea Medidata Solutions K.K. Japan Medidata Technology LLP United Kingdom Medidata Technology Partner, LLC |
|
| March 1, 2019 |
EX-10.23 2 hsbcmedidata-amendmentno1.htm EXHIBIT 10.23 AMENDMENT NO. 1 AMENDMENT NO. 1, dated as of December 10, 2018 (this “Amendment”), among Medidata Solutions, Inc., a corporation organized under the laws of Delaware (the “Borrower”), the Lenders party hereto and HSBC Bank USA, National Association (“HSBC”), as Administrative Agent (in such capacity, the “Administrative Agent”). The Borrower, |
|
| March 1, 2019 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Medidat |
|
| February 16, 2019 |
8-K 1 form8-k21519.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdi |
|
| February 14, 2019 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0039160sc13ga.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 13)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Nu |
|
| February 12, 2019 |
Medidata Reports Fourth Quarter 2018 Results EX-99.1 2 a51939127ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Fourth Quarter 2018 Results NEW YORK-(BUSINESS WIRE)-February 12, 2019-Medidata (NASDAQ:MDSO) today announced its financial results for the fourth quarter of 2018. “In 2018, we expanded our market leadership in life sciences, and proved that our unique data and AI capabilities can reinvent the way treatments are developed and |
|
| February 12, 2019 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51939127.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 12, 2019 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdictio |
|
| February 11, 2019 |
MDSO / Medidata Solutions, Inc. / VANGUARD GROUP INC Passive Investment medidatasolutionsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 6 )* Name of issuer: Medidata Solutions Inc Title of Class of Securities: Common Stock CUSIP Number: 58471A105 Date of Event Which Requires Filing of this Statement: December 31, 2018 Check the appropri |
|
| October 30, 2018 |
MDSO / Medidata Solutions, Inc. FORM 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3438 |
|
| October 23, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 19, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Num |
|
| October 23, 2018 |
Medidata Appoints Dr. Maria Rivas to its Board of Directors EX-99.1 2 rivaspressrelease10-22x2018.htm EXHIBIT 99.1 Medidata Appoints Dr. Maria Rivas to its Board of Directors Appointment is initial step toward company pledge to 2020 Women on Boards initiative NEW YORK-(BUSINESS WIRE)-Oct. 22, 2018- Medidata (NASDAQ: MDSO) announced today that it has appointed Dr. Maria Rivas to its Board of Directors. An endocrinologist with extensive experience as a senio |
|
| October 18, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51885146.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 18, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction |
|
| October 18, 2018 |
Medidata Reports Third Quarter 2018 Results EX-99.1 2 a51885146ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Third Quarter 2018 Results NEW YORK-(BUSINESS WIRE)-October 18, 2018-Medidata (NASDAQ:MDSO) today announced its financial results for the third quarter of 2018. “Our strong financial and operational performance this quarter highlight the momentum and success we are seeing in the market,” said Tarek Sherif, chairman and chief e |
|
| September 26, 2018 |
MDSO / Medidata Solutions, Inc. CORRESP September 26, 2018 Kathleen Collins Accounting Branch Chief - Office of Information Technologies and Services United States Securities and Exchange Commission Division of Corporation Finance Washington, D. |
|
| September 6, 2018 |
MDSO / Medidata Solutions, Inc. CORRESP September 6, 2018 Kathleen Collins Accounting Branch Chief - Office of Information Technologies and Services United States Securities and Exchange Commission Division of Corporation Finance Washington, D. |
|
| August 2, 2018 |
MDSO / Medidata Solutions, Inc. FORM 10-Q (Quarterly Report) Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Med |
|
| August 1, 2018 |
Unregistered Sales of Equity Securities 8-K 1 mdso8-kxconvert.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporatio |
|
| July 24, 2018 |
Medidata Reports Second Quarter 2018 Results Exhibit 99.1 Medidata Reports Second Quarter 2018 Results NEW YORK-(BUSINESS WIRE)-July 24, 2018-Medidata (NASDAQ: MDSO) today announced its financial results for the second quarter of 2018. “We executed well operationally and delivered strong business results this quarter and in the first half of the year, all while closing our largest acquisition to date,” said Tarek Sherif, chairman and chief e |
|
| July 24, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 24, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| June 22, 2018 |
Medidata Solutions, Inc. Third Amended and Restated 2014 Employee Stock Purchase Plan Exhibit 99.1 MEDIDATA SOLUTIONS, INC. THIRD AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN 1. Purpose. The purpose of the Medidata Solutions, Inc. Third Amended and Restated 2014 Employee Stock Purchase Plan (the “Plan”) is to provide eligible employees of Medidata Solutions, Inc. (the “Company”) and its Subsidiaries with a convenient way to purchase shares of the Company’s common stock (t |
|
| June 22, 2018 |
MDSO / Medidata Solutions, Inc. FORM S-8 As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. |
|
| June 22, 2018 |
Amended and Restated 2017 Long-Term Incentive Plan EX-99.1 4 ex991-mdsoltip2018sx8.htm EXHIBIT 99.1 Exhibit 99.1 MEDIDATA SOLUTIONS, INC. AMENDED AND RESTATED 2017 LONG-TERM INCENTIVE PLAN ARTICLE 1 GENERAL 1.1 Purpose. The purpose of the Plan is to establish a vehicle through which the Company can provide equity-based and other incentive compensation opportunities in order to facilitate its ability to recruit, motivate, reward and retain talented |
|
| June 22, 2018 |
MDSO / Medidata Solutions, Inc. FORM S-8 As filed with the Securities and Exchange Commission on June 22, 2018 Registration No. |
|
| June 20, 2018 |
Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 20, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| June 12, 2018 |
EX-2.1 2 mergeragreement.htm EXHIBIT 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among MEDIDATA SOLUTIONS, INC. STORM MERGER SUB, INC. SHYFT ANALYTICS, INC. AND STORM SELLER REPRESENTATIVE LLC As Stockholders’ Representative June 11, 2018 TABLE OF CONTENTS Page ARTICLE I THE MERGER 2 1.1 The Merger 2 1.2 General Effects of the Merger 3 1.3 Effects of the Merger on Securities of Mergi |
|
| June 12, 2018 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 11, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| May 31, 2018 |
Submission of Matters to a Vote of Security Holders 8-K 1 post-agm8xk.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001 |
|
| May 4, 2018 |
Form of Medidata Solutions, Inc. 2018 Performance-Based Restricted Stock Unit Agreement EX-10.1 2 a2018pbrsuagreement.htm EXHIBIT 10.1 MEDIDATA SOLUTIONS, INC. 2018 PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT is made as of February 20th, 2018, by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and [PARTICIPANT] (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. 2017 Long-Term Incentive Plan (the “Plan”), the Company hereby grants |
|
| May 4, 2018 |
MDSO / Medidata Solutions, Inc. FORM 10-Q (Quarterly Report) 10-Q 1 medidat-3312018x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2018 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fro |
|
| April 19, 2018 |
MDSO / Medidata Solutions, Inc. DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☐ Definitive Proxy State |
|
| April 19, 2018 |
MDSO / Medidata Solutions, Inc. DEF 14A TABLE OF CONTENTS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) ☒ Defi |
|
| April 19, 2018 |
Medidata Reports First Quarter 2018 Results EX-99.1 2 a51791569ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports First Quarter 2018 Results Total revenue of $149.2 million, representing 17% year-over-year growth GAAP operating margin of 8.9%; non-GAAP operating margin of 22.9%, representing 120 basis points year-over-year margin expansion Total multi-year subscription backlog, unadjusted for renewals, of $1.0 billion as of March 31, 2018 |
|
| April 19, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 19, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Numbe |
|
| February 28, 2018 |
Subsidiaries of Medidata Solutions, Inc. EX-21.1 3 subsidiariesoftheregistran.htm SUBSIDIARIES OF MEDIDATA SOLUTIONS, INC. Exhibit 21.1 MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant Subsidiaries* Place of Incorporation MDSOL Europe Limited United Kingdom Medidata Holdings, Inc. Delaware, U.S. Medidata Korea, Limited South Korea Medidata Solutions K.K. Japan Medidata Technology LLP United Kingdom Medidata Technology Partner, LLC |
|
| February 28, 2018 |
MDSO / Medidata Solutions, Inc. FORM 10-K (Annual Report) 10-K 1 a10-k2017.htm FORM 10-K Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission |
|
| February 28, 2018 |
EX-10.16 2 mcaponeseparationagreement.htm EXHIBIT 10.16 350 Hudson Street Floor 9 New York, NY 10014 United States mdsol.com December 20, 2017 Michael Capone Address on file Dear Mike: This Letter Agreement incorporating the annexed General Release (collectively sometimes referred to as the “Agreement”) contains the terms and conditions applicable to your separation from employment with Medidata S |
|
| February 23, 2018 |
8-K 1 a2018execxcomp.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 20, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other juris |
|
| February 22, 2018 |
POWER OF ATTORNEY Know all by these presents, that the undersigned, as a Section 16 reporting person of Medidata Solutions, Inc. |
|
| February 14, 2018 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0030625sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 12)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP N |
|
| February 9, 2018 |
MDSO / Medidata Solutions, Inc. / VANGUARD GROUP INC Passive Investment SC 13G/A 1 medidatasolutionsinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 5 )* Name of issuer: Medidata Solutions Inc Title of Class of Securities: Common Stock CUSIP Number: 58471A105 Date of Event Which Requires Filing of this Statement: December 31, 2017 Check the appropriate box to designate the rule pur |
|
| February 8, 2018 |
Medidata Reports Record Full-Year and Fourth Quarter 2017 Results Exhibit 99.1 Medidata Reports Record Full-Year and Fourth Quarter 2017 Results Full-year total revenue of $545.5 million, representing 18% year-over-year growth Full-year GAAP net income of $44.4 million, or $0.74 per diluted share, up 53% year-over-year Total multi-year unadjusted subscription backlog1 of $1.0 billion as of December 31, 2017, up 39% year-over-year Provides 2018 total revenue guid |
|
| February 8, 2018 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 8, 2018 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Num |
|
| December 28, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 21, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Nu |
|
| December 28, 2017 |
Exhibit CREDIT AGREEMENT dated as of December 21, 2017 among MEDIDATA SOLUTIONS, INC. |
|
| December 13, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 13, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Nu |
|
| November 3, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3438 |
|
| November 3, 2017 |
Form of Medidata Solutions, Inc. Nonstatutory Stock Option Agreement MEDIDATA SOLUTIONS, INC. NONSTATUTORY STOCK OPTION AGREEMENT AGREEMENT made as of the [DAY] day of [MONTH], 2017, by and between MEDIDATA SOLUTIONS, INC. (the ?Company?), and [PARTICIPANT] (the ?Participant?). 1.Grant of Option. In accordance with the Medidata Solutions, Inc. 2017 Long-Term Incentive Plan (the ?Plan?), the Company grants to the Participant an option to purchase up to [###] shares |
|
| October 26, 2017 |
Medidata Reports Record Third Quarter 2017 Results Exhibit 99.1 Medidata Reports Record Third Quarter 2017 Results Record revenue of $140.1 million, representing 17% year-over-year growth Record GAAP net income of $12.8 million, representing 75% year-over-year growth Record year-to-date cash flow from operations of $91.6 million, representing 89% year-over-year growth NEW YORK-(BUSINESS WIRE)-October 26, 2017-Medidata (NASDAQ:MDSO), the leading gl |
|
| October 26, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51705666.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 26, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction |
|
| August 1, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-6302017x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to |
|
| August 1, 2017 |
Form of Medidata Solutions, Inc. Restricted Stock Agreement EX-10.2 2 a2017ltiprestrictedstockag.htm EXHIBIT 10.2 MEDIDATA SOLUTIONS, INC. RESTRICTED STOCK AGREEMENT AGREEMENT made as of the [DAY] day of [MONTH], [YEAR], by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and [PARTICIPANT] (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. 2017 Long-Term Incentive Plan (the “Plan”), the Company has made a restricted stock aw |
|
| July 18, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| July 18, 2017 |
Medidata Reports Record Second Quarter 2017 Results EX-99.1 2 a51590459ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Second Quarter 2017 Results Record revenue of $137.4 million, representing 20% year-over-year growth GAAP net income of $8.3 million, or $0.14 per diluted share, up 33% year-over-year Cash flow from operations of $38.2 million, representing 31% year-over-year growth NEW YORK-(BUSINESS WIRE)-July 18, 2017-Medidata (NASDA |
|
| June 20, 2017 |
CORRESP 1 filename1.htm June 20, 2017 Kathleen Collins Accounting Branch Chief- Office of Information Technologies & Services United States Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: Medidata Solutions, Inc. Form 10-K for the fiscal year ended December 31, 2016 Filed February 28, 2017 Form 10-Q for the period ended March 31, 2017 Filed May 8, 2017 |
|
| June 2, 2017 |
Submission of Matters to a Vote of Security Holders 8-K 1 mdso-xform8xk.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 30, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 0 |
|
| May 30, 2017 |
Medidata Solutions, Inc. 2017 Long-Term Incentive Plan Exhibit 99.1 MEDIDATA SOLUTIONS, INC. 2017 LONG-TERM INCENTIVE PLAN ARTICLE 1 GENERAL 1.1 Purpose . The purpose of the Plan is to establish a vehicle through which the Company can provide equity-based and other incentive compensation opportunities in order to facilitate its ability to recruit, motivate, reward and retain talented individuals who contribute or are expected to contribute to the succ |
|
| May 30, 2017 |
Document As filed with the Securities and Exchange Commission on May 30, 2017 Registration No. |
|
| May 8, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-3312017x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2017 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from t |
|
| May 8, 2017 |
Form of Medidata Solutions, Inc. 2017 Performance-Based Restricted Stock Unit Agreement EX-10.1 2 formof2017pbrsuagreement.htm EXHIBIT 10.1 MEDIDATA SOLUTIONS, INC. 2017 PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT is made as of February 23rd, 2017, by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. 2009 Long-Term Incentive Plan (the “Plan”), the Company hereby grants to the Pa |
|
| April 26, 2017 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 26, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Numbe |
|
| April 26, 2017 |
Medidata Reports Record First Quarter 2017 Results Exhibit 99.1 Medidata Reports Record First Quarter 2017 Results Record revenue of $126.8 million, representing 22% year-over-year growth GAAP net income of $9.5 million, or $0.16 per diluted share, up 108% year-over-year Cash flow from operations of $22.5 million, representing 63% year-over-year growth NEW YORK-(BUSINESS WIRE)-April 26, 2017-Medidata (NASDAQ:MDSO), the leading global provider of c |
|
| April 19, 2017 |
DEFA14A 1 d356406ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ |
|
| April 19, 2017 |
Medidata Solutions NOTICE & PROXY DEF 14A 1 d316149ddef14a.htm NOTICE & PROXY Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant ☒ Filed by a Party other than the Registrant ☐ Check the appropriate box: ☐ Preliminary Proxy Statement ☐ Confidential, for Use of the Commission On |
|
| March 1, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 23, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commiss |
|
| February 28, 2017 |
MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant EX-21.1 2 subsidiariesoftheregistran.htm SUBSIDIARIES OF MEDIDATA SOLUTIONS, INC. Exhibit 21.1 MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant Subsidiaries* Place of Incorporation MDSOL Europe Limited United Kingdom Medidata International, Inc. Delaware, U.S. Medidata Korea, Limited South Korea Medidata Solutions K.K. Japan Medidata Technology LLP United Kingdom Medidata Technology Partner |
|
| February 28, 2017 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Medidat |
|
| February 27, 2017 |
POWER OF ATTORNEY Know all by these presents, that the undersigned, as a Section 16 reporting person of Medidata Solutions, Inc. |
|
| February 27, 2017 |
POWER OF ATTORNEY Know all by these presents, that the undersigned, as a Section 16 reporting person of Medidata Solutions, Inc. |
|
| February 10, 2017 |
Medidata Solutions 3G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 medidatasolutionsinc.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 4 )* Name of issuer: Medidata Solutions Inc Title of Class of Securities: Common Stock CUSIP Number: 58471A105 Date of Event Which Requires Filing of this Statement: December 31, 2016 Check the appropriate box to designate the rule pur |
|
| February 9, 2017 |
Medidata Solutions MEDIDATA SOLUTIONS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 9, 2017 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Num |
|
| February 9, 2017 |
Medidata Reports Record Full-Year and Fourth Quarter 2016 Results Exhibit 99.1 Medidata Reports Record Full-Year and Fourth Quarter 2016 Results Full-year total revenue of $463.4 million, representing 18% year-over-year growth Q4 total revenue of $124.5 million, representing 26% year-over-year growth Full-year GAAP net income of $29.0 million, or $0.51 per diluted share, up 120% year-over-year Adjusted subscription backlog1 of $404 million as of December 31, 201 |
|
| February 9, 2017 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0023898sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 11)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP N |
|
| December 7, 2016 |
8-K 1 mdso8kx12072016.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 1, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporat |
|
| November 3, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-09302016x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period f |
|
| October 25, 2016 |
Medidata Solutions MEDIDATA SOLUTIONS, INC. 8-K (Current Report/Significant Event) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 25, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Num |
|
| October 25, 2016 |
Medidata Reports Record Third Quarter 2016 Results EX-99.1 2 a51445733ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Third Quarter 2016 Results Record revenues of $120.1 million, a 5% sequential increase Quarterly subscription revenue tops $100 million for the first time totaling $101.6 million GAAP net income of $7.4 million, or $0.13 per diluted share, a 57% year-over-year increase Reaffirms full-year 2016 total revenue and profitab |
|
| August 15, 2016 |
Amended and Restated Executive Change in Control Agreement for CEO and President EX-10.1 2 d246371dex101.htm EX-10.1 Exhibit 10.1 MEDIDATA SOLUTIONS, INC. AMENDED AND RESTATED EXECUTIVE CHANGE IN CONTROL AGREEMENT AGREEMENT made as of the 9th day of August, 2016, by and between MEDIDATA SOLUTIONS, INC. (“Company”) and [ ] (“Executive”). 1. Background. The parties have previously signed an Executive Change in Control Agreement dated as of January 20, 2009, and amended as of Mar |
|
| August 15, 2016 |
8-K 1 d246371d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): August 9, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction |
|
| August 5, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Med |
|
| August 1, 2016 |
August 1, 2016 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Kathleen Collins Re: Medidata Solutions, Inc. Form 10-K for the year ended December 31, 2015 Filed February 29, 2016 File No. 001-34387 Ladies and gentlemen: Medidata Solutions, Inc. (the “Company”) submits this letter in response to the comments from the Staf |
|
| July 20, 2016 |
Medidata Reports Record Second Quarter 2016 Results EX-99.1 2 a51384602ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Second Quarter 2016 Results Record revenues of $114.6 million, a 10% sequential and 17% year-over-year increase Record subscription revenue of $96.8 million, an 8% sequential and 15% year-over-year increase Reiterates full-year 2016 total revenue and profitability guidance NEW YORK-(BUSINESS WIRE)-July 20, 2016-Medidata |
|
| July 20, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51384602.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 20, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of |
|
| July 1, 2016 |
CORRESP 1 filename1.htm *FOIA Confidential Treatment Request* Confidential Treatment Requested By Medidata Solutions, Inc. Pursuant to 17 C.F.R. §200.83 July 1, 2016 U.S. Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Kathleen Collins Re: Medidata Solutions, Inc. Form 10-K for the year ended December 31, 2015 Filed February 2 |
|
| June 9, 2016 |
S-8 1 d192657ds8.htm FORM S-8 As filed with the Securities and Exchange Commission on June 9, 2016 Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-8 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 13-4066508 (State or other jurisdiction of incorporat |
|
| June 9, 2016 |
MEDIDATA SOLUTIONS, INC. SECOND AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN EX-99.1 Exhibit 99.1 MEDIDATA SOLUTIONS, INC. SECOND AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN 1. Purpose. The purpose of the Medidata Solutions, Inc. Second Amended and Restated 2014 Employee Stock Purchase Plan (the ?Plan?) is to provide eligible employees of Medidata Solutions, Inc. (the ?Company?) and its Subsidiaries with a convenient way to purchase shares of the Company?s commo |
|
| June 7, 2016 |
8-K 1 d205685d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): June 1, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction o |
|
| June 7, 2016 |
EX-3.1 2 d205685dex31.htm EX-3.1 Exhibit 3.1 CERTIFICATE OF AMENDMENT OF FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MEDIDATA SOLUTIONS, INC. Medidata Solutions, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware, hereby certifies as follows: 1. This Certificate of Amendment (the “Certificate of Amendment”) amend |
|
| June 1, 2016 |
CORRESP 1 filename1.htm June 1, 2016 U.S. Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Attention: Kathleen Collins Re: Medidata Solutions, Inc. Form 10-K for the year ended December 31, 2015 Filed February 29, 2016 File No. 001-34387 Ladies and gentlemen: Medidata Solutions, Inc. (the “Company”) submits this letter in response to the comments from the S |
|
| May 23, 2016 |
CORRESP 1 filename1.htm May 23, 2016 Ms. Joyce Sweeney U.S. Securities and Exchange Commission Division of Corporation Finance Washington, D.C. 20549 Re: Staff’s comment letter dated May 10, 2016 Dear Ms. Sweeney: This will confirm our earlier telephone conversation in which I requested to extend the time for Medidata to furnish its responses to the Staff’s comments. Thank you for your considerati |
|
| May 9, 2016 |
Form of Medidata Solutions, Inc. Performance-Based Restricted Stock Unit Agreement MEDIDATA SOLUTIONS, INC. 2016 PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT is made as of February 26, 2016, by and between MEDIDATA SOLUTIONS, INC. (the “ Company ”), and (the “ Participant ”). 1.Award. In accordance with the Medidata Solutions, Inc. 2009 Long-Term Incentive Plan (the “Plan”), the Company hereby grants to the Participant a target incentive award for a total of |
|
| May 9, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-03312016x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from |
|
| April 21, 2016 |
DEFA14A 1 d183911ddefa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: ¨ |
|
| April 21, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51325003.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 21, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction o |
|
| April 21, 2016 |
Medidata Reports Record First Quarter 2016 Results EX-99.1 2 a51325003ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record First Quarter 2016 Results Record revenues of $104.2 million, a 13% year-over-year increase Record subscription revenue of $90.0 million, a 14% year-over-year increase Expands market share with Bristol-Myers Squibb deal, Medidata’s third top 25 enterprise platform customer win in the last six months NEW YORK-(BUSINESS W |
|
| April 21, 2016 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 11, 2016 |
PRE 14A 1 d131351dpre14a.htm PRE 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant x Filed by a Party other than the Registrant ¨ Check the appropriate box: x Preliminary Proxy Statement ¨ Confidential, for Use of the Commission Only (as |
|
| April 11, 2016 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0019006sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 10)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP N |
|
| March 8, 2016 |
Medidata Solutions 3G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 fp0018505sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 9)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Nu |
|
| March 3, 2016 |
8-K 1 form8-k3316.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 26, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdic |
|
| February 29, 2016 |
MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant EX-21.1 2 subsidiariesoftheregistran.htm SUBSIDIARIES OF MEDIDATA SOLUTIONS, INC. Exhibit 21.1 MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant Subsidiaries* Place of Incorporation MDSOL Europe Limited United Kingdom Medidata International, Inc. Delaware, U.S. Medidata Korea, Limited South Korea Medidata Solutions K.K. Japan Medidata Technology LLP United Kingdom Medidata Technology Partner |
|
| February 29, 2016 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Medidat |
|
| February 16, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 11, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commiss |
|
| February 16, 2016 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0018031sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 8)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Nu |
|
| February 16, 2016 |
Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF MEDIDATA SOLUTIONS, INC. (initially adopted on June 30, 2009 effective as of the closing of the corporations initial public offering) (as amended on February 11, 2016) TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 2.3 SPECIAL MEETING 1 2.4 NO |
|
| February 10, 2016 |
MDSO / Medidata Solutions, Inc. / VANGUARD GROUP INC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 3 )* Name of issuer: Medidata Solutions Inc Title of Class of Securities: Common Stock CUSIP Number: 58471A105 Date of Event Which Requires Filing of this Statement: December 31, 2015 Check the appropriate box to designate the rule pursuant to which this Schedule is file |
|
| February 10, 2016 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51276709.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 10, 2016 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdictio |
|
| February 10, 2016 |
Medidata Reports Full-Year and Fourth Quarter 2015 Results EX-99.1 2 a51276709ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Full-Year and Fourth Quarter 2015 Results Record full-year revenue of $392.5 million, a 17% year-over-year increase Record full-year subscription revenue of $336.2 million, a 20% year-over-year increase Record full-year new client wins of 201, a 52% year-over-year increase Record full-year cash flow from operations of $87.0 mi |
|
| February 9, 2016 |
SC 13G/A 1 mdso13gdec15.htm MDSO AS OF 12/31/2015 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) MEDIDATA SOLUTIONS INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 58471A105 (CUSIP Number) December 31, 2015 (Date of Event which Requires Filing of Statement) Check the appropriate box t |
|
| January 6, 2016 |
POWER OF ATTORNEY Know all by these presents, that the undersigned, as a Section 16 reporting person of Medidata Solutions, Inc. |
|
| November 5, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ? QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 OR ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-3438 |
|
| October 27, 2015 |
Medidata Reports Record Third Quarter 2015 Results EX-99.1 2 a51209960ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Third Quarter 2015 Results Record revenues of $103.1 million, a 20% year-over-year increase Record subscription revenue of $88.9 million, a 24% year-over-year increase Record cash flow from operations of $27.7 million, a 23% year-over-year increase NEW YORK-(BUSINESS WIRE)-October 27, 2015-Medidata (NASDAQ:MDSO), the le |
|
| October 27, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51209960.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 27, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction |
|
| October 6, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Numb |
|
| August 10, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Med |
|
| July 27, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 22, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commission |
|
| July 27, 2015 |
EX-3.1 2 d55802dex31.htm EX-3.1 Exhibit 3.1 AMENDED AND RESTATED BYLAWS OF MEDIDATA SOLUTIONS, INC. (initially adopted on June 30, 2009 effective as of the closing of the corporation’s initial public offering) (as amended on July 22, 2015) TABLE OF CONTENTS Page ARTICLE I CORPORATE OFFICES 1 1.1 REGISTERED OFFICE 1 ARTICLE II MEETINGS OF STOCKHOLDERS 1 2.1 PLACE OF MEETINGS 1 2.2 ANNUAL MEETING 1 |
|
| July 21, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 21, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| July 21, 2015 |
Medidata Reports Record Second Quarter 2015 Revenues EX-99.1 2 a51145767ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Second Quarter 2015 Revenues Record revenues of $98.1 million, 18% year-over-year increase Record subscription revenue of $83.9 million, 22% year-over-year increase Record second quarter billings of $106 million, 36% year-over-year increase Reiterates 2015 revenue and profitability guidance NEW YORK-(BUSINESS WIRE)-July |
|
| May 29, 2015 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 27, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commission F |
|
| May 18, 2015 |
BergmannDraftPOA11 POWER OF ATTORNEY Know all by these presents, that the undersigned, as a Section 16 reporting person of Medidata Solutions, Inc. |
|
| May 14, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 13, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commission F |
|
| May 14, 2015 |
EX-10.1 2 d926661dex101.htm EX-10.1 Exhibit 10.1 May 13, 2015 Cory Douglas c/o Medidata Solutions, Inc. 350 Hudson Street New York, NY 10014 Dear Cory, This Letter Agreement incorporating the annexed General Release (collectively sometimes referred to as the “Agreement”) contains the terms and conditions applicable to your separation from employment with Medidata Solutions, Inc. or any applicable |
|
| May 11, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-3312015x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2015 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from t |
|
| April 23, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 23, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Numbe |
|
| April 23, 2015 |
EX-99.2 3 a51086429ex992.htm EXHIBIT 99.2 Exhibit 99.2 Medidata Announces CFO Transition; Rouven Bergmann, CFO SAP North America to Join as Chief Financial Officer; Reaffirms 2015 Guidance NEW YORK-(BUSINESS WIRE)-April 23, 2015-Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Rouven Bergmann is joining the co |
|
| April 23, 2015 |
Medidata Reports Record First Quarter 2015 Revenues EX-99.1 2 a51086429ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record First Quarter 2015 Revenues Record revenues of $92.4 million, a 21% year-over-year increase Record subscription revenue of $78.7 million, a 23% year-over-year increase Cash flow from operations of $16.9 million NEW YORK-(BUSINESS WIRE)-April 23, 2015-Medidata (NASDAQ:MDSO), the leading global provider of cloud-based sol |
|
| April 15, 2015 |
DEF 14A Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 15, 2015 |
DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ? Check the appropriate box: ? Preliminary Proxy Statement ? |
|
| March 2, 2015 |
MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant Exhibit 21.1 MEDIDATA SOLUTIONS, INC. Subsidiaries of the Registrant Subsidiaries Place of Incorporation MDSOL Europe Limited United Kingdom Medidata International, Inc. Delaware, U.S. Medidata Korea, Limited South Korea Medidata Solutions K.K. Japan Medidata Technology LLP United Kingdom |
|
| March 2, 2015 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Medidat |
|
| February 20, 2015 |
8-K 1 d877650d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 13, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdict |
|
| February 12, 2015 |
SC 13G 1 mdso13gdec14.htm MDSO AS OF 12/31/2014 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. ) MEDIDATA SOLUTIONS INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 58471A105 (CUSIP Number) December 31, 2014 (Date of Event which Requires Filing of Statement) Check the appropriate box to d |
|
| February 11, 2015 |
MDSO / Medidata Solutions, Inc. / VANGUARD GROUP INC Passive Investment medidatasolutionsinc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 2 )* Name of issuer: Medidata Solutions Inc Title of Class of Securities: Common Stock CUSIP Number: 58471A105 Date of Event Which Requires Filing of this Statement: December 31, 2014 Check the appropri |
|
| February 5, 2015 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 7)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Number) December 31, 2014 (Date o |
|
| February 5, 2015 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a51033746.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 5, 2015 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction |
|
| February 5, 2015 |
Medidata Reports Record Full Year and Fourth Quarter 2014 Revenues Exhibit 99.1 Medidata Reports Record Full Year and Fourth Quarter 2014 Revenues Record full year revenue of $335.1 million, a 21% year-over-year increase Record full year subscription revenue of $280.0 million, a 23% year-over-year increase Provides 2015 revenue guidance of between $392 and $412 million NEW YORK-(BUSINESS WIRE)-February 5, 2015-Medidata (NASDAQ:MDSO), the leading global provider o |
|
| November 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-9302014x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr |
|
| October 28, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition 8-K 1 a50970787.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 28, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction |
|
| October 28, 2014 |
Medidata Reports Record Third Quarter 2014 Revenues EX-99.1 2 a50970787ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Third Quarter 2014 Revenues Record revenues of $86.0 million, a 21% year-over-year increase Record subscription revenue of $71.5 million, a 23% year-over-year increase Revises 2014 guidance NEW YORK-(BUSINESS WIRE)-October 28, 2014-Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinica |
|
| September 25, 2014 |
8-K 1 d795328d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 18, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdic |
|
| September 24, 2014 |
Medidata Appoints Mike Capone Chief Operating Officer EX-99.1 2 d794264dex991.htm EX-99.1 Exhibit 99.1 FOR IMMEDIATE RELEASE Medidata Appoints Mike Capone Chief Operating Officer NEW YORK, N.Y. – September 24, 2014 – Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that Michael L. Capone is joining the company as chief operating officer (COO). In the newly created CO |
|
| September 24, 2014 |
Form 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): September 24, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation |
|
| August 20, 2014 |
MEDIDATA SOLUTIONS, INC. AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN EX-99.1 Exhibit 99.1 MEDIDATA SOLUTIONS, INC. AMENDED AND RESTATED 2014 EMPLOYEE STOCK PURCHASE PLAN 1. Purpose. The purpose of the Medidata Solutions, Inc. Amended and Restated 2014 Employee Stock Purchase Plan (the “Plan”) is to provide eligible employees of Medidata Solutions, Inc. (the “Company”) and its Subsidiaries with a convenient way to purchase shares of the Company’s common stock (the “ |
|
| August 20, 2014 |
MDSO / Medidata Solutions, Inc. S-8 - - FORM S-8 As filed with the Securities and Exchange Commission on August 20, 2014 Registration No. |
|
| August 7, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-6302014x10q.htm 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Comm |
|
| August 7, 2014 |
Fifth Amended and Restated Certificate of Incorporation Exhibit 3.1 FIFTH AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF MEDIDATA SOLUTIONS, INC. a Delaware corporation MEDIDATA SOLUTIONS, INC. (the “Corporation”), a corporation organized and existing under the laws of the State of Delaware, does hereby certify that: A.The name of the Corporation is Medidata Solutions, Inc. The date of the filing of the original Certificate of Incorporation of th |
|
| July 29, 2014 |
Medidata Reports Record Second Quarter 2014 Results EX-99.1 2 a50913929ex991.htm EXHIBIT 99.1 Exhibit 99.1 Medidata Reports Record Second Quarter 2014 Results Record revenues of $83.2 million, a 22% year-over-year increase Record subscription revenue of $68.9 million, a 22% year-over-year increase Reiterates 2014 revenue guidance NEW YORK-(BUSINESS WIRE)-July 29, 2014-Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for |
|
| July 29, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 29, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Number |
|
| July 9, 2014 |
EX-10.1 2 d755962dex101.htm EX-10.1 Exhibit 10.1 July 8, 2014 Steven Wilhite Dear Steven: This Letter Agreement incorporating the annexed General Release (collectively sometimes referred to as the “Agreement”) contains the terms and conditions applicable to your separation from employment with Medidata Solutions, Inc. or any applicable subsidiary thereof (the “Company”) and is in full settlement o |
|
| July 9, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 8, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commission F |
|
| July 8, 2014 |
8-K 1 d756602d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 1, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction o |
|
| July 8, 2014 |
Form of Executive Change in Control Agreement EX-10.1 2 d756602dex101.htm EX-10.1 Exhibit 10.1 MEDIDATA SOLUTIONS, INC. EXECUTIVE CHANGE IN CONTROL AGREEMENT WITH [EXECUTIVE] AGREEMENT made as of the day of [ ], by and between MEDIDATA SOLUTIONS, INC. (“Company”) and [ ] (“Executive”). 1. Background. This Agreement is intended to provide Executive with certain payments and benefits upon an involuntary termination of Executive’s employment or |
|
| May 30, 2014 |
Submission of Matters to a Vote of Security Holders 8-K 1 d734399d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 28, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001- |
|
| April 30, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2014 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Me |
|
| April 22, 2014 |
Medidata Reports Record First Quarter 2014 Results Exhibit 99.1 Medidata Reports Record First Quarter 2014 Results Record revenues of $76.6 million, a 21% year-over-year increase Record subscription revenue of $63.8 million, a 26% year-over-year increase Record billings of $90 million, a 43% year-over-year increase NEW YORK-(BUSINESS WIRE)-April 22, 2014-Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions for clinical rese |
|
| April 22, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 22, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Numbe |
|
| April 16, 2014 |
- DEFINITIVE ADDITIONAL MATERIALS DEFA14A 1 d708784ddefa14a.htm DEFINITIVE ADDITIONAL MATERIALS UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant ¨ Chec |
|
| April 15, 2014 |
DEF 14A 1 d683424ddef14a.htm DEFINITIVE PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Regis |
|
| April 2, 2014 |
PRE 14A 1 d683424dpre14a.htm PRELIMINARY PROXY STATEMENT Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Regi |
|
| February 25, 2014 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Medidat |
|
| February 25, 2014 |
The Rector, Church-Wardens and Vestrymen of Trinity Church in the City of New York 75 Varick Street, 2nd Floor New York, New York 10013 September 25, 2013 Medidata Solutions, Inc. |
|
| February 25, 2014 |
EX-10.16 3 mdso-12312013xex1016.htm EX-10.16 SECOND AMENDMENT OF LEASE THIS SECOND AMENDMENT OF LEASE, dated as of the 6th day of December, 2013 (this “Agreement”), made by and between THE RECTOR, CHURCH-WARDENS AND VESTRYMEN OF TRINITY CHURCH IN THE CITY OF NEW YORK, a religious corporation, having its office at 75 Varick Street, 2nd Floor, New York, New York 10013 (“Landlord”), and MEDIDATA SOLU |
|
| February 13, 2014 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): February 10, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commiss |
|
| February 13, 2014 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0009588sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 6)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Nu |
|
| February 11, 2014 |
MDSO / Medidata Solutions, Inc. / VANGUARD GROUP INC Passive Investment medidatasolutioninc.htm - Generated by SEC Publisher for SEC Filing SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.: 1 )* Name of issuer: Medidata Solutions Inc Title of Class of Securities: Common Stock CUSIP Number: 58471A105 Date of Event Which Requires Filing of this Statement: December 31, 2013 Check the appropria |
|
| February 6, 2014 |
Medidata Reports Record Full Year and Fourth Quarter 2013 Results Exhibit 99.1 Medidata Reports Record Full Year and Fourth Quarter 2013 Results Record full year revenue of $276.8 million, a 27% year-over-year increase Record full year subscription revenue of $227.9 million, a 33% year-over-year increase Raises 2014 revenue guidance to between $340 and $345 million NEW YORK-(BUSINESS WIRE)-February 6, 2014-Medidata (NASDAQ:MDSO), the leading global provider of c |
|
| February 6, 2014 |
Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 6, 2014 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Num |
|
| December 13, 2013 |
As filed with the Securities and Exchange Commission on December 13, 2013 Registration No. |
|
| December 13, 2013 |
MEDIDATA SOLUTIONS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN EX-99.1 Exhibit 99.1 MEDIDATA SOLUTIONS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN 1. Purpose. The purpose of the Medidata Solutions, Inc. 2014 Employee Stock Purchase Plan (the “Plan”) is to provide eligible employees of Medidata Solutions, Inc. (the “Company”) and its Subsidiaries with a convenient way to purchase shares of the Company’s common stock (the “Common Stock”). It is believed that partic |
|
| November 21, 2013 |
Medidata Raises Long-Term Revenue Growth Target to 20-25% FOR IMMEDIATE RELEASE Medidata Raises Long-Term Revenue Growth Target to 20-25% NEW YORK, N. |
|
| November 21, 2013 |
Financial Statements and Exhibits, Other Events 8-K 1 mdso-1121138k.htm MEDIDATA SOLUTIONS, INC. 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 21, 2013 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdi |
|
| November 12, 2013 |
Financial Statements and Exhibits, Other Events UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 11, 2013 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Nu |
|
| November 12, 2013 |
Medidata Solutions Announces Two-for-One Stock Split EX-99.1 2 mdso-111213ex991.htm EXHIBIT 99.1 FOR IMMEDIATE RELEASE Medidata Solutions Announces Two-for-One Stock Split NEW YORK, N.Y. – November 11, 2013 – Medidata Solutions (NASDAQ: MDSO), the leading global provider of cloud-based solutions for clinical research in life sciences, today announced that its Board of Directors has approved a two-for-one (2:1) split of the Company's common stock at |
|
| November 4, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-9302013x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fr |
|
| October 24, 2013 |
Medidata Solutions Reports Record Third Quarter 2013 Results Exhibit 99.1 Medidata Solutions Reports Record Third Quarter 2013 Results Record revenues of $70.9 million, a 27% year-over-year increase Record application services revenue of $57.9 million, a 32% year-over-year increase Raises 2013 revenue guidance to between $275.3 and $276.8 million NEW YORK-(BUSINESS WIRE)-October 24, 2013-Medidata Solutions (NASDAQ: MDSO), the leading global provider of clou |
|
| October 24, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2013 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-34387 (Commission File Num |
|
| September 10, 2013 |
MDSO / Medidata Solutions, Inc. / BROWN CAPITAL MANAGEMENT LLC Passive Investment SC 13G/A 1 fp0008225sc13ga.htm SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (AMENDMENT NO. 5)* Medidata Solutions, Inc. (Name of Issuer) Common Stock, Par Value $0.01 (Title of Class of Securities) 58471A105 (CUSIP Nu |
|
| August 12, 2013 |
8-K 1 d581583d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2013 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of i |
|
| August 12, 2013 |
EX-4.1 2 d581583dex41.htm EX-4.1 Exhibit 4.1 MEDIDATA SOLUTIONS, INC. AND WELLS FARGO BANK, NATIONAL ASSOCIATION, as Trustee INDENTURE Dated as of August 12, 2013 1.00% Convertible Senior Notes due 2018 TABLE OF CONTENTS PAGE ARTICLE 1 DEFINITIONS Section 1.01. Definitions 1 Section 1.02. References to Interest 11 ARTICLE 2 ISSUE, DESCRIPTION, EXECUTION, REGISTRATION AND EXCHANGE OF NOTES Section |
|
| August 2, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q 10-Q 1 mdso-6302013x10q.htm FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to |
|
| July 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 25, 2013 Medidata Solutions, Inc. (Exact name of registrant as specified in its charter) Delaware 001-34387 13-4066508 (State or other jurisdiction of incorporation) (Commission |
|
| July 25, 2013 |
Medidata Solutions Reports Record Second Quarter 2013 Results Exhibit 99.1 Medidata Solutions Reports Record Second Quarter 2013 Results Record revenues of $68.1 million, a 27% year-over-year increase Record application services revenue of $56.3 million, a 36% year-over-year increase Raises 2013 revenue guidance to between $273 and $276 million NEW YORK-(BUSINESS WIRE)-July 25, 2013-Medidata Solutions (NASDAQ: MDSO), the leading global provider of cloud-base |
|
| May 3, 2013 |
FORM OF MEDIDATA SOLUTIONS, INC. LONG-TERM PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT EX-10.3 4 mdso-3312013xex103.htm EX-10.3 FORM OF MEDIDATA SOLUTIONS, INC. LONG-TERM PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT is made as of , by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. 2009 Long-Term Incentive Plan (the “Plan”), and subject to the terms and conditions of this agre |
|
| May 3, 2013 |
Form of Medidata Solutions, Inc. Restricted Stock Agreement MEDIDATA SOLUTIONS, INC. RESTRICTED STOCK AGREEMENT AGREEMENT made as of the day of , 20, by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. 2009 Long-Term Incentive Plan (the “Plan”), the Company has made a restricted stock award to the Participant for shares of the Company’s common stock (the “Shares”). The a |
|
| May 3, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2013 OR ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-34387 Me |
|
| May 3, 2013 |
As filed with the Securities and Exchange Commission on May 3, 2013 Registration No. |
|
| May 3, 2013 |
FORM OF MEDIDATA SOLUTIONS, INC. PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT EX-10.2 3 mdso-3312013xex102.htm EX-10.2 FORM OF MEDIDATA SOLUTIONS, INC. PERFORMANCE-BASED RESTRICTED STOCK UNIT AGREEMENT THIS AGREEMENT is made as of [ ], by and between MEDIDATA SOLUTIONS, INC. (the “Company”), and (the “Participant”). 1.Award. In accordance with the Medidata Solutions, Inc. 2009 Long-Term Incentive Plan (the “Plan”), the Company hereby grants to the Participant a target incen |
|
| May 2, 2013 |
Medidata Solutions, Inc. Second Amended and Restated 2009 Long-Term Incentive Plan EX-10.1 2 d529130dex101.htm EX-10.1 Exhibit 10.1 MEDIDATA SOLUTIONS, INC. SECOND AMENDED AND RESTATED 2009 LONG-TERM INCENTIVE PLAN ARTICLE 1 GENERAL 1.1 Purpose. The purpose of the Plan is to provide a flexible vehicle for offering equity-based and other incentive opportunities designed to attract, motivate and retain eligible employees, directors and other eligible persons who contribute to the |
